Enlaza Therapeutics has filed a notice of an exempt offering of securities to raise $110 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Enlaza Therapeutics is raising up to $110,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Sergio Duron played a…
